An assessment of new product development in the Irish pharmaceutical industry

Séamus Enright; Kathryn Cormican

doi:10.13025/18987

An assessment of new product development in the Irish pharmaceutical industry

Séamus Enright
, Kathryn Cormican

Mechanical Engineering

Research output: Chapter in Book or Conference Publication/Proceeding › Conference Publication › peer-review

Abstract

In today's competitive drug development environment, Irish pharmaceutical companies are moving towards more knowledge base activities. These companies must focus on new product development (NPD) firstly to remain competitive and ultimately to survive. This work assesses the current NPD process in the Irish pharmaceutical industry by examining models from literature and quantitative research in the form of a survey. Integration and communication of project management and NPD systems is critical. The requirement for improvements in information flow, performance management, risk management and the development of a cohesive costing system is highlighted.

Original language	English (Ireland)
Title of host publication	10th International Product Development Management Conference
Place of Publication	Brussels, Belgium
DOIs	https://doi.org/10.13025/18987
Publication status	Published - 1 Jun 2003

Access to Document

10.13025/18987Licence: CC BY-NC-ND

IPDMCAccepted author manuscript, 192 KBLicence: CC BY-NC-ND

Cite this

@inproceedings{ab254aa2d55e447cac619a33c0084c9d,

title = "An assessment of new product development in the Irish pharmaceutical industry",

abstract = "In today's competitive drug development environment, Irish pharmaceutical companies are moving towards more knowledge base activities. These companies must focus on new product development (NPD) firstly to remain competitive and ultimately to survive. This work assesses the current NPD process in the Irish pharmaceutical industry by examining models from literature and quantitative research in the form of a survey. Integration and communication of project management and NPD systems is critical. The requirement for improvements in information flow, performance management, risk management and the development of a cohesive costing system is highlighted.",

author = "S{\'e}amus Enright and Kathryn Cormican",

year = "2003",

month = jun,

day = "1",

doi = "10.13025/18987",

language = "English (Ireland)",

booktitle = "10th International Product Development Management Conference",

}

TY - GEN

T1 - An assessment of new product development in the Irish pharmaceutical industry

AU - Enright, Séamus

AU - Cormican, Kathryn

PY - 2003/6/1

Y1 - 2003/6/1

N2 - In today's competitive drug development environment, Irish pharmaceutical companies are moving towards more knowledge base activities. These companies must focus on new product development (NPD) firstly to remain competitive and ultimately to survive. This work assesses the current NPD process in the Irish pharmaceutical industry by examining models from literature and quantitative research in the form of a survey. Integration and communication of project management and NPD systems is critical. The requirement for improvements in information flow, performance management, risk management and the development of a cohesive costing system is highlighted.

AB - In today's competitive drug development environment, Irish pharmaceutical companies are moving towards more knowledge base activities. These companies must focus on new product development (NPD) firstly to remain competitive and ultimately to survive. This work assesses the current NPD process in the Irish pharmaceutical industry by examining models from literature and quantitative research in the form of a survey. Integration and communication of project management and NPD systems is critical. The requirement for improvements in information flow, performance management, risk management and the development of a cohesive costing system is highlighted.

UR - http://hdl.handle.net/10379/4079

U2 - 10.13025/18987

DO - 10.13025/18987

M3 - Conference Publication

BT - 10th International Product Development Management Conference

CY - Brussels, Belgium

ER -

An assessment of new product development in the Irish pharmaceutical industry

Abstract

Access to Document

Other files and links

Fingerprint

Cite this